Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer. The research, from the group of Professor Sophia Karagiannis at King's ...

Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer. Engineered for precision T-cell activation in prostate cancer; part of Aptevo's growing CRIS ...

Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research ...

Fine-tuned by the immune system to latch onto a particular site on a pathogen, Y-shaped antibodies bind to their targets with their arms. Meanwhile, the Fc region (or "stem") of the antibody ...

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...

Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a ...

This idea of controlling antibody activity by making them more rigid seems to apply to many other similar molecules on immune cells." Dr. Ivo Tews, Professor in Structural Biology at Southampton ...

Fruit bats generate more diverse antibodies than mice, but overall have a weaker antibody response, according to a new study published September 24 in the open-access journal PLOS Biology by Dan ...

Immune and antibody responses against the original SARS-CoV-2 (D614G) and Omicron (B.1.1.529) strains were evaluated up to 14 months after boosting.

Infectious Disease > COVID-19 New Monoclonal Authorized to Prevent COVID in Immunocompromised People — No such option has been available since FDA revoked the authorization of Evusheld last year ...